Last reviewed · How we verify

NCT06250361: FAST

Identification of Factors ASsociaTed With a Delayed Diagnosis in Crohn's Disease

Status unknown Last updated 9 February 2024
What this trial tests

trial testing Questionnaire completion in Crohn Disease in 600 participants. Status unknown.

Timeline
15 February 2024
Primary endpoint
15 February 2025
15 June 2025

Quick facts

Lead sponsorGroupe d'Etude Therapeutique des Affections Inflammatoires Digestives
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment600
Start date15 February 2024
Primary completion15 February 2025
Estimated completion15 June 2025

Drugs / interventions tested

Conditions studied

Sponsor

Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives — full company profile →

Who can join

Adults 18 to 75, any sex, with Crohn Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to determine the factors associated with a delayed diagnosis and/or an immediately complicated disease for CD patients. A questionnaire will be completed by the patients, each questionnaire has a patient section and a physician section.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Questionnaire completion

Trials testing the same drug.

Other recruiting trials for Crohn Disease

Currently open trials in the same condition.

Other Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06250361.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing